Quattromed

Quattromed Ltd
Privately held company
Industry Biotechnology, Biopharmaceutical industry
Founded 1999
Headquarters Tartu, Estonia
Key people
 Mart Ustav, CEO
Products Products and services in functional genomics and proteomics, latex allergen tests
Services Certification: ISO 9001:2000
Website www.quattromed.com

Quattromed Ltd is one of the leading biotechnology companies in Estonia[1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. As of 2 March 2009, Icosagen AS is the new business name of the former Quattromed Ltd.

Profile

Quattromed was established in 1999 as a spin-off from Tartu University.[2] It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics (Quattromed HTI Laboratories), life science products (Quattromed), latex allergen testing (Quattromed Ltd) and protein production (Quattromed Cell Factory).

Products and services

Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.

Quattromed’s main products are:

See also

References

  1. ↑ Frank L. (2001). "Biotechnology in the Baltic". Nature Biotechnology. 19 (6): 513–5. doi:10.1038/89229. PMID 11385442.
  2. ↑ Estonian Biotechnology Association Archived October 21, 2007, at the Wayback Machine.. Retrieved 18. June 2007.
  3. ↑ Kurg R; Parik J; Juronen E; Sedman T; Abroi A; Liiv I; Langel U; Ustav M. (1999). "Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication". Journal of Virology. 73 (6): 4670–7. PMC 112508Freely accessible. PMID 10233926.
  4. ↑ Kaldalu N; Lepik D; Kristjuhan A; Ustav M. (2000). "Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags.". Biotechniques. 28 (3): 456–60. PMID 10723557.
This article is issued from Wikipedia - version of the 11/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.